Summary
The provided claims do not align with the supplied FDA-approved labeling excerpts for Aspirin and Extended-Release Dipyridamole Capsules (stroke risk reduction). Most claims describe general aspirin pharmacology and multiple non-labeled indications/safety and interaction statements not supported by the provided label text, and therefore cannot be verified against the supplied prescribing information.
Category Scores
Accurate Statements
Unsupported Statements
Aspirin is a nonsteroidal anti-inflammatory drug (NSAID).
Not supported by the supplied label excerpts (Indications 1, Dosage 2, Clinical Studies 14).
Aspirin works by blocking the production of prostaglandins.
Mechanism statement not supported by the supplied label excerpts.
When ingested, aspirin is broken down into salicylic acid.
Pharmacokinetic/metabolism statement not supported by the supplied label excerpts.
Salicylic acid inhibits the enzyme cyclooxygenase (COX).
Mechanism statement not supported by the supplied label excerpts.
Aspirin inhibits the production of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1β).
Immunologic/cytokine mechanism not supported by the supplied label excerpts.
Aspirin can reduce pain and inflammation in osteoarthritis.
Non-labeled indication; the supplied label excerpt indicates stroke risk reduction.
Aspirin can reduce joint pain and inflammation in rheumatoid arthritis.
Non-labeled indication; the supplied label excerpt indicates stroke risk reduction.
Aspirin is commonly used to treat tension headaches.
Non-labeled indication; the supplied label excerpt indicates stroke risk reduction.
Aspirin is commonly used to treat migraines.
Non-labeled indication; the supplied label excerpt indicates stroke risk reduction.
Aspirin can reduce pain and inflammation in muscles and joints.
Non-labeled indication; not supported by the supplied label excerpts.
Aspirin can reduce pain from inflammation.
Non-labeled/general efficacy statement not supported by the supplied label excerpts.
Aspirin’s anti-inflammatory effects may help reduce the risk of heart disease by preventing the formation of blood clots.
Not supported by the supplied label excerpt (Indication is stroke risk reduction).
Some studies have suggested that aspirin may lower the risk of certain cancers, such as colon cancer.
Not supported by the supplied label excerpts.
Aspirin may have neuroprotective effects that could help improve cognitive function in older adults.
Not supported by the supplied label excerpts.
Aspirin can cause gastrointestinal side effects including stomach ulcers and bleeding.
Adverse reaction not supported by the supplied label excerpts.
Aspirin is more likely to cause stomach ulcers and bleeding when taken in high doses or for extended periods.
Dose-duration risk statement not supported by the supplied label excerpts.
Aspirin can interact with blood thinners.
Drug interaction not supported by the supplied label excerpts.
Aspirin interactions with other medications can decrease their effectiveness.
General interaction/efficacy statement not supported by the supplied label excerpts.
Taking aspirin regularly can lead to overuse.
Overuse claim not supported by the supplied label excerpts.
Overuse of aspirin can cause rebound headaches and other adverse effects.
Rebound headache/overuse claim not supported by the supplied label excerpts.
Aspirin can exacerbate stomach ulcers and bleeding.
Adverse reaction/exacerbation claim not supported by the supplied label excerpts.
Aspirin should be used with caution during pregnancy and breastfeeding.
Pregnancy/breastfeeding caution statement not supported by the supplied label excerpts.
Aspirin should be used during pregnancy and breastfeeding only under the guidance of a healthcare professional.
Specific use guidance in pregnancy/breastfeeding not supported by the supplied label excerpts.
Contradictions
Important Omissions
FDA-approved indication: reduce the risk of stroke in patients with transient ischemia of the brain or completed ischemic stroke due to thrombosis.
Importance:
High
FDA-approved dosing/administration for this capsule: one capsule orally twice daily (morning and evening), swallow whole without chewing; can be administered with or without food; not interchangeable with individual components.
Importance:
High
Safety Assessment
Potential Patient Risk:
High
The claims focus on non-labeled indications (pain/inflammation conditions, headaches/migraines, cancer risk, cognitive effects, heart disease risk) and multiple safety/interaction statements that are not supported by the provided labeling excerpts. Such unsupported information could mislead use or expectations versus the labeled stroke-risk indication.
Regulatory Assessment
| On Label |
No |
| Off-label Discussion |
Yes |
| Promotes Unapproved Use |
No |
| Hallucination Risk |
High |
Recommendation
Not Aligned
Primary Issue
Most claims are not supported by the supplied FDA label excerpts and introduce multiple non-labeled indications and safety/pharmacology statements.
Suggested Improvement
Restrict statements to the supplied label excerpts: (1) labeled indication for reducing stroke risk after TIA or completed ischemic stroke due to thrombosis, and (2) labeled dosing/administration instructions and non-interchangeability; avoid unsupported general aspirin pharmacology and non-labeled therapeutic uses.